{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-25-000103","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.021615+00:00","generated_at":"2026-05-17T22:32:05.396937+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stryker Q2 2025: net sales $6.0B +11.1%, adj EPS $3.13 +11.4%, raises FY guidance","bullets":["Net sales $6.0B +11.1% reported (+10.2% organic); MedSurg/Neuro +17.3%, Orthopaedics +2.0% (ex-spinal +10.7%).","Reported EPS $2.29 +7.0%; adjusted EPS $3.13 +11.4%. Adj. operating margin 25.7% +110 bps.","FY 2025 guidance raised: organic sales growth 9.5-10.0%, adj EPS $13.40-$13.60.","Tariff impact estimated at ~$175M net, reflecting US-China reduction and proposed US-EU framework."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-25-000103","json":"https://secwatch.observer/filing/0000310764-25-000103.json","markdown":"https://secwatch.observer/filing/0000310764-25-000103.md","text":"https://secwatch.observer/filing/0000310764-25-000103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000103/0000310764-25-000103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000103/syk-20250731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:32:05.396937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}